The multi-target small-molecule inhibitor SB747651A shows in vitro and in vivo anticancer efficacy in glioblastomas
Abstract Glioblastoma multiforme is the most common primary brain tumor and among the most lethal types of cancer. Several mono-target small molecule-inhibitors have been investigated as novel therapeutics, thus far with poor success. In this study we investigated the anticancer effects of SB747651A...
Enregistré dans:
Auteurs principaux: | Arnon Møldrup Knudsen, Henning Bünsow Boldt, Elisabeth Victoria Jakobsen, Bjarne Winther Kristensen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/eb0995e2ff9d49fc8f512f48a138a289 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion
par: Anne Schuster, et autres
Publié: (2020) -
Small molecule inhibitor of OGG1 blocks oxidative DNA damage repair at telomeres and potentiates methotrexate anticancer effects
par: Juan Miguel Baquero, et autres
Publié: (2021) -
9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
par: Hiroo Kuroki, et autres
Publié: (2019) -
Case Report: Malignant Primary Sellar Paraganglioma With Unusual Genetic and Imaging Features
par: Stefan Stojanoski, et autres
Publié: (2021) -
Antitheilerial Activity of the Anticancer Histone Deacetylase Inhibitors
par: Madhumanti Barman, et autres
Publié: (2021)